Jailani, Nancy B.

HRN: 27-22-29  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
AMPICILLIN 1GM (VIAL)
05/30/2025
05/31/2025
IV
2 G
Q6
PROM , Thickly MSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: